Company announcement - No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metab ...
No. 10 / 2026Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved ...
Today, on World Day for Safety and Health at Work, you need to look at how occupational conditions impact your physical ...
Researchers have long considered the Stuxnet attacks on Iran's nuclear centrifuges in Natanz to be the opening chapter of ...
South Wales Argus on MSN
Council unhappy with its own planning app and online system
Monmouthshire County Council has identified several issues with its planning portal and MyMonmouthshire app according to a recent council meeting.
Manufacturers can build a foundational data infrastructure that enables them to adopt agents faster and with less outright ...
The increasing use of digital technology in India’s economy has created new opportunities for economic development and capital investment. The transformation process has created new weaknesses through ...
WinMagic exposes the "Wrong Identity Tax," where organizations invest heavily in identity security that still fails to ...
APPF trades at 25x forward earnings, making its valuation unattractive given competitive and AI-related risks. Read more on ...
Whenever I hit the leaderboard at Orangetheory, I post the triumph to Instagram stories with the same caption: “My midlife ...
Humanity is gradually conquering incurable genetic diseases that were once considered untreatable, thanks to a series of ...
Additional Presentations at ASGCT Showcase Tenaya’s Work with Patients to Advance Gene Therapy and Early-Stage Pipeline Innovations in Cardiac Gene Editing SOUTH SAN FRANCISCO, Calif., April 27, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results